CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - OSL:CONTX - SE0014731154 - Common Stock
4.58 NOK
+0.02 (+0.44%)
CONTX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 9 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
CONTX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CONTX has a Return On Assets of 10.31%. This is amongst the best in the industry. CONTX outperforms 88.89% of its industry peers.
The Return On Equity of CONTX (14.29%) is better than 77.78% of its industry peers.
CONTX has a better Return On Invested Capital (12.59%) than 100.00% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 9.36%.
The last Return On Invested Capital (12.59%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROIC | 12.59% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
Looking at the Profit Margin, with a value of 10.66%, CONTX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CONTX's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 12.82%, CONTX is doing good in the industry, outperforming 77.78% of the companies in the same industry.
CONTX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 97.41%, CONTX belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of CONTX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
CONTX has about the same amout of shares outstanding than it did 1 year ago.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
CONTX's Debt to FCF ratio of 0.50 is fine compared to the rest of the industry. CONTX outperforms 77.78% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that CONTX is not too dependend on debt financing.
CONTX has a better Debt to Equity ratio (0.08) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Altman-Z | N/A |
ROIC/WACC1.83
WACC6.89%
2.3 Liquidity
A Current Ratio of 3.66 indicates that CONTX has no problem at all paying its short term obligations.
CONTX has a better Current ratio (3.66) than 100.00% of its industry peers.
A Quick Ratio of 3.59 indicates that CONTX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.59, CONTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
CONTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
CONTX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
The Revenue has been growing slightly by 7.78% on average over the past years.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
3.2 Future
The Earnings Per Share is expected to grow by 0.74% on average over the next years.
CONTX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.20% yearly.
EPS Next Y-28.88%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
EPS Next 5Y0.74%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-0.2%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.41, the valuation of CONTX can be described as very reasonable.
CONTX's Price/Earnings ratio is rather cheap when compared to the industry. CONTX is cheaper than 88.89% of the companies in the same industry.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (27.30), we can say CONTX is valued rather cheaply.
With a Price/Forward Earnings ratio of 19.10, CONTX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, CONTX is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
CONTX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.41 | ||
| Fwd PE | 19.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX indicates a somewhat cheap valuation: CONTX is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CONTX is valued cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.43 | ||
| EV/EBITDA | 11.25 |
4.3 Compensation for Growth
The excellent profitability rating of CONTX may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -5.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
Compared to an average industry Dividend Yield of 3.53, CONTX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
OSL:CONTX (9/15/2025, 2:08:43 PM)
4.58
+0.02 (+0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners10.82%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap354.35M
Analysts40
Price Target5.1 (11.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.09%
PT rev (3m)-9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-46.34%
EPS NY rev (3m)-46.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.39%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.41 | ||
| Fwd PE | 19.1 | ||
| P/S | 2.74 | ||
| P/FCF | 17.43 | ||
| P/OCF | 12.83 | ||
| P/B | 3.67 | ||
| P/tB | 3.81 | ||
| EV/EBITDA | 11.25 |
EPS(TTM)0.44
EY9.61%
EPS(NY)0.24
Fwd EY5.24%
FCF(TTM)0.26
FCFY5.74%
OCF(TTM)0.36
OCFY7.79%
SpS1.67
BVpS1.25
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROCE | 15.94% | ||
| ROIC | 12.59% | ||
| ROICexc | 44.69% | ||
| ROICexgc | 50.4% | ||
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% | ||
| FCFM | 15.71% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.84% | ||
| Profit Quality | 147.45% | ||
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z | N/A |
F-Score4
WACC6.89%
ROIC/WACC1.83
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-26.55%
EPS Next 3Y-5.88%
EPS Next 5Y0.74%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-12.48%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-0.2%
EBIT growth 1Y-60.97%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-3.57%
EBIT Next 3Y20.51%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-34.27%
OCF growth 3Y51.49%
OCF growth 5Y5.6%